CareDx (CDNA) Competitors $13.10 +0.37 (+2.91%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$13.10 0.00 (0.00%) As of 09/4/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDNA vs. PRVA, VCYT, HTFL, CELC, ADUS, LFST, PGNY, ARDT, PACS, and NHCShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Privia Health Group (PRVA), Veracyte (VCYT), Heartflow (HTFL), Celcuity (CELC), Addus HomeCare (ADUS), LifeStance Health Group (LFST), Progyny (PGNY), Ardent Health (ARDT), PACS Group (PACS), and National HealthCare (NHC). These companies are all part of the "healthcare" industry. CareDx vs. Its Competitors Privia Health Group Veracyte Heartflow Celcuity Addus HomeCare LifeStance Health Group Progyny Ardent Health PACS Group National HealthCare Privia Health Group (NASDAQ:PRVA) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership. Do analysts rate PRVA or CDNA? Privia Health Group presently has a consensus target price of $28.58, indicating a potential upside of 23.63%. CareDx has a consensus target price of $27.67, indicating a potential upside of 111.20%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than Privia Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Privia Health Group 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.93CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Does the media refer more to PRVA or CDNA? In the previous week, Privia Health Group had 7 more articles in the media than CareDx. MarketBeat recorded 13 mentions for Privia Health Group and 6 mentions for CareDx. CareDx's average media sentiment score of 1.15 beat Privia Health Group's score of 0.86 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, PRVA or CDNA? Privia Health Group has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, CareDx has a beta of 2.28, suggesting that its share price is 128% more volatile than the S&P 500. Which has higher earnings & valuation, PRVA or CDNA? CareDx has lower revenue, but higher earnings than Privia Health Group. CareDx is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrivia Health Group$1.74B1.63$14.39M$0.11210.18CareDx$333.79M2.09$52.55M$1.0212.84 Is PRVA or CDNA more profitable? CareDx has a net margin of 17.97% compared to Privia Health Group's net margin of 0.78%. CareDx's return on equity of 18.03% beat Privia Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Privia Health Group0.78% 2.13% 1.25% CareDx 17.97%18.03%12.88% Do institutionals & insiders believe in PRVA or CDNA? 94.5% of Privia Health Group shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by company insiders. Comparatively, 4.4% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCareDx beats Privia Health Group on 9 of the 17 factors compared between the two stocks. Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$677.58M$7.67B$5.76B$9.85BDividend YieldN/A2.68%6.67%4.51%P/E Ratio12.8478.0775.9926.43Price / Sales2.0945.49546.94119.09Price / Cash9.3623.6237.0558.92Price / Book1.867.3510.916.06Net Income$52.55M$238.91M$3.29B$266.28M7 Day Performance-4.10%-0.82%0.18%-0.32%1 Month Performance1.95%2.80%6.26%3.44%1 Year Performance-51.71%11.26%51.54%23.11% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx4.054 of 5 stars$13.10+2.9%$27.67+111.2%-52.7%$677.58M$333.79M12.84740Positive NewsPRVAPrivia Health Group4.0013 of 5 stars$21.40-2.7%$28.00+30.8%+22.5%$2.70B$1.74B199.911,140News CoverageAnalyst ForecastVCYTVeracyte3.1994 of 5 stars$29.55-4.7%$40.90+38.4%+6.7%$2.44B$445.76M33.70790Positive NewsHTFLHeartflowN/A$29.84+2.3%N/AN/A$2.37BN/A0.00699Trending NewsAnalyst ForecastCELCCelcuity0.8759 of 5 stars$49.25-6.0%$50.60+2.7%+248.9%$2.22BN/A0.0040Short Interest ↑ADUSAddus HomeCare4.8457 of 5 stars$116.65-1.5%$138.38+18.6%-14.3%$2.18B$1.15B25.7549,703Positive NewsAnalyst ForecastLFSTLifeStance Health Group3.4872 of 5 stars$5.39-2.9%$8.50+57.7%-18.4%$2.16B$1.25B0.0010,218Positive NewsPGNYProgyny3.1072 of 5 stars$23.14-1.7%$25.10+8.5%-1.0%$2.02B$1.17B42.78310Positive NewsARDTArdent Health3.631 of 5 stars$12.70-2.2%$19.56+54.1%-34.7%$1.86B$5.97B7.1724,900Positive NewsPACSPACS Group3.15 of 5 stars$11.75-2.5%$33.33+183.7%-69.5%$1.84B$3.11B0.0032,433NHCNational HealthCareN/A$111.98-2.5%N/A-12.3%$1.74B$1.46B14.0312,400 Related Companies and Tools Related Companies Privia Health Group Alternatives Veracyte Alternatives Heartflow Alternatives Celcuity Alternatives Addus HomeCare Alternatives LifeStance Health Group Alternatives Progyny Alternatives Ardent Health Alternatives PACS Group Alternatives National HealthCare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDNA) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDNA Stock Alerts